{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:04:08Z","timestamp":1790388248729,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,10,11]],"date-time":"2004-10-11T00:00:00Z","timestamp":1097452800000},"content-version":"vor","delay-in-days":5154,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Neuroscience Research"],"published-print":{"date-parts":[[1990,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinal cord monoaminergic and peptidergic axonal damage occurring during the development of experimental allergic encephalomyelitis (EAE) was assessed using immunohistochemistry. Spinal cord axons immunoreactive for serotonin, catecholamines, or a thyrotropin\u2010releasing hormone marker peptide were found to be markedly swollen and distorted by the earliest stage of detectable paralysis during EAE development (the flaccid tail stage). As clinical signs progressed to complete hindlimb paralysis, axonal damage became increasingly extensive. Axonal damage was equally pronounced whether EAE was induced by inoculation with purified myelin basic protein or with whole spinal cord homogenate, suggesting that the damage did not result from an immune attack directed against specific monoaminergic and\/or peptidergic antigens present in the inoculant. However, two observations suggested that mechanical or chemical factors associated with the inflammatory foci contribute to the axonal damage: first, distorted axons were nearly always located adjacent to blood vessels or the pial surface, sites at which inflammation occurs during EAE. Second, the severity of axonal damage correlated with the severity of the inflammation. The early onset of axonal damage during development of EAE and the close correlation that was found between the severity of axonal damage and the severity of clinical signs suggested that the axonal damage may contribute to the clinical signs of the disease.<\/jats:p>","DOI":"10.1002\/jnr.490270114","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T05:39:47Z","timestamp":1104557987000},"page":"89-98","source":"Crossref","is-referenced-by-count":17,"title":["Damage to bulbospinal serotonin\u2010, tyrosine hydroxylase\u2010, and TRH\u2010containing axons occurs early in the development of experimental allergic encephalomyelitis in rats"],"prefix":"10.1002","volume":"27","author":[{"given":"S. R.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. K.","family":"Samathanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Bowker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"Wessendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,11]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"352","article-title":"The effects of 5\u2010hydroxytryprophan and L\u2010tryptophan on spinal synaptic activity","volume":"153","author":"Anderson EG","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1139\/y84-038"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1974.tb08601.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.18.2.118"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(81)90208-6"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(71)90631-7"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90333-0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(81)90160-9"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.17.5915"},{"key":"e_1_2_1_11_1","first-page":"1","article-title":"Evidence for the existence of monoamine neurons in the central system. II. Experimentally induced changes in the intraneuronal amine levels of the bulbospinal neuron system","volume":"247","author":"Dahlstrom A","year":"1965","journal-title":"Acta Physiol Scand [Suppl]"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(81)90006-X"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(82)90154-3"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)91168-6"},{"key":"e_1_2_1_15_1","first-page":"131","article-title":"Neurotransmitters, precursors and metabolites in spinal cord and brain in Lewis rats with experimental allergic encephalomyelitis","volume":"146","author":"Honegger CG","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/29.4.6166661"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)90847-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)91013-8"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90055-9"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1986.tb00747.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687386"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-126-32475"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000231052"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(89)90068-4"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)91405-7"},{"key":"e_1_2_1_26_1","first-page":"817","article-title":"The action of thyrotropin\u2010releasing hormone, substance P and related peptides on frog spinal motoneurons","volume":"207","author":"Nicoll RA","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_27_1","first-page":"179","volume-title":"Textbook of Immunopathology","author":"Paterson PY","year":"1976"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(87)90003-8"},{"key":"e_1_2_1_29_1","first-page":"608","article-title":"Analysis of autoimmune demyelination; its impact upon multiple sclerosis","volume":"50","author":"Raine CS","year":"1984","journal-title":"Lab Invest"},{"key":"e_1_2_1_30_1","first-page":"174","article-title":"Augmentation of immune\u2010mediated demyelination by lipid haptens","volume":"45","author":"Raine CS","year":"1981","journal-title":"Lab Invest"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1523\/JNEUROSCI.02-11-01660.1982","article-title":"Immunocytochemical analysis of serotonergic axons in laminae 1 and 11 of the lumbar spinal cord of the cat","volume":"2","author":"Ruda MA","year":"1983","journal-title":"J Neurosci"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(82)90034-0"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(85)90225-8"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(81)90146-9"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(88)90142-X"},{"key":"e_1_2_1_36_1","unstructured":"WessendorfMW AppelNM MolitorTW EldeRP: Characterization of a method for the immunofluorescent demonstration of three coexisting neurotransmitters using the fluorophores fluorescein (green) lissamine\u2010rhodamine (red) 7\u2010amino\u20104\u2010methylcoumarin\u20103\u2010acetic acid (AMCA blue).J Histochem Cytochem: in press."},{"key":"e_1_2_1_37_1","first-page":"776","article-title":"Anatomical distribution of immunoreactivity for prepro TRH160\u2013169, a possible marker for TRM neurons","volume":"13","author":"Wessendorf MW","year":"1987","journal-title":"Soc Neurosci Abst"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)91196-4"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1983.tb08156.x"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(88)90136-1"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90561-2"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(85)90203-9"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(89)90019-2"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410010207"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90616-4"}],"container-title":["Journal of Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjnr.490270114","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jnr.490270114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T15:49:24Z","timestamp":1697989764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jnr.490270114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["10.1002\/jnr.490270114"],"URL":"https:\/\/doi.org\/10.1002\/jnr.490270114","archive":["Portico"],"relation":{},"ISSN":["0360-4012","1097-4547"],"issn-type":[{"value":"0360-4012","type":"print"},{"value":"1097-4547","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}